S-ICD as a First-Line Therapy:
Results from the PRAETORIAN and UNTOUCHED Trials
Results from the PRAETORIAN Trial
Presented by Dr Reinoud Knops, Academic Medical Center, Amsterdam
Moderated by Dr Ulrika Birgersdotter-Green, University of California, San Diego
Results from the UNTOUCHED Trial
Presented by Dr Michael Gold, Medical University of South Carolina
Moderated by Dr Ulrika Birgersdotter-Green, University of California, San Diego
Results from the PRAETORIAN and UNTOUCHED Trials Q&A
Presenters:
Dr Reinoud Knops, Academic Medical Center, Amsterdam
Dr Michael Gold, Medical University of South Carolina
Moderated by Dr Ulrika Birgersdotter-Green, University of California, San Diego
Past and Current Perceptions of the clinical need for ATP. Dr. Roser discusses Selecting the right therapy for the right patient. Are we treating patients according to their indications today?
A growing Patients Role in today’s Healthcare: Prof. John Morgan and S-ICD patient Lindsay Davis discuss the psychological and clinical impact of an ICD implant and important pre-implant considerations.
3-Yrs of follow-up in ~1000 patients demonstrates S-ICD safety & efficacy is comparable to TV-ICDs while avoiding the serious complications associated with having a lead in the heart.
As we stand at the threshold of a truly transformative change in how we provide therapy to patients at risk of cardiac arrhythmias, discover more about the evolution of sudden cardiac death prevention and how we are now looking forward to what patients are going to need in the next 5, 10, 15 years.
